Figure 1From: Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastasesKaplan-Meier analysis of local control after SRT/SRS treatment of a brainstem metastasis. The 6 month and 12 month actuarial control rates were 93%.Back to article page
